Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

EVFM US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

EVFM US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Evofem Biosciences, Inc.(EVFM US)

$0.01+0.006.90%(Market Open · 20:50:22 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized

Evofem Biosciences, Inc.(EVFM US)

$0.01+0.006.90%(Market Open · 20:50:22 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings

SEC Filings

Financials(52)

Expand
  • 10-QQ3ended 30 Sept 202604:57PM
  • 10-QQ2ended 30 Jun 202614 Aug
  • 10-QQ1ended 31 Mar 202615 May
  • 10-KFY 2025ended 31 Dec 202511 Mar
  • 10-QQ3ended 30 Sept 202513 Nov 2025
  • 10-QQ2ended 30 Jun 202514 Aug 2025
  • 10-QQ1ended 31 Mar 202515 May 2025
  • 10-K/AFY 2024ended 31 Dec 202428 Mar 2025
  • 10-KFY 2024ended 31 Dec 202424 Mar 2025
  • 10-QQ3ended 30 Sept 202414 Nov 2024
  • 10-QQ2ended 30 Jun 202414 Aug 2024
  • 10-QQ1ended 31 Mar 202415 May 2024
  • 10-KFY 2023ended 31 Dec 202327 Mar 2024
  • 10-QQ3ended 30 Sept 202314 Nov 2023
  • 10-QQ2ended 30 Jun 202314 Aug 2023

Events(246)

Expand
  • 8-KResults of Operations and Financial Condition04:59PM
  • 8-KEntry into a Material Definitive Agreement15 Oct
  • 8-KEntry into a Material Definitive Agreement23 Sep
  • 8-KRegulation FD Disclosure20 Jul
  • 8-KEntry into a Material Definitive Agreement14 Jul
  • 8-KResults of Operations and Financial Condition18 May
  • 8-KEntry into a Material Definitive Agreement30 Apr
  • 8-KEntry into a Material Definitive Agreement16 Apr
  • 8-KTermination of a Material Definitive Agreement19 Mar
  • 8-KResults of Operations and Financial Condition11 Mar
  • 8-KRegulation FD Disclosure12 Jan
  • 8-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year26 Nov 2025
  • 8-KResults of Operations and Financial Condition13 Nov 2025
  • 8-KTermination of Material Agreement20 Oct 2025
  • 8-KEntry into Material Agreement17 Oct 2025

Insider Ownership(281)

Expand
  • Form 4Zhang Yan12 Jan 2024
  • Form 4Kamdar Kim P.22 Dec 2023
  • Form 5File Justin J.8 May 2023
  • Form 3Zhang Yan26 Apr 2023
  • Form 4PELLETIER SAUNDRA L26 Apr 2023
  • Form 3Yip Jenny C.8 Aug 2022
  • Form 3Atkinson Katherine Cocca7 Jun 2022
  • Form 4PELLETIER SAUNDRA L31 May 2022
  • Form 4O'Brien Anthony Stephen6 May 2022
  • Form 4Kamdar Kim P.6 May 2022
  • Form 4Rarick Lisa Dale6 May 2022
  • Form 4Rutherford Colin6 May 2022
  • Form 4Greer Gillian6 May 2022
  • Form 4Fitzpatrick Alexander A23 Feb 2022
  • Form 4PELLETIER SAUNDRA L23 Feb 2022

Beneficial Ownership(56)

Expand
  • SC 13DEvofem Biosciences, Inc.4 Aug
  • SC 13G/AEvofem Biosciences, Inc.14 Feb 2024
  • SC 13G/AEvofem Biosciences, Inc.14 Feb 2023
  • SC 13G/AEvofem Biosciences, Inc.10 Aug 2022
  • SC 13GEvofem Biosciences, Inc.19 Jul 2022
  • SC 13G/AEvofem Biosciences, Inc.14 Feb 2022
  • SC 13G/AEvofem Biosciences, Inc.10 Sep 2021
  • SC 13G/AEvofem Biosciences, Inc.12 Jul 2021
  • SC 13GEvofem Biosciences, Inc.4 Jun 2021
  • SC 13GEvofem Biosciences, Inc.28 May 2021
  • SC 13D/AEvofem Biosciences, Inc.20 May 2021
  • SC 13D/AEvofem Biosciences, Inc.27 Apr 2021
  • SC 13D/AEvofem Biosciences, Inc.31 Mar 2021
  • SC 13G/AEvofem Biosciences, Inc.12 Feb 2021
  • SC 13GEvofem Biosciences, Inc.2 Feb 2021

Proxies(43)

Expand
  • DEF 14ADefinitive proxy statement29 Oct 2025
  • PRE 14APreliminary proxy statement20 Oct 2025
  • DEFA14ADefinitive additional materials19 Sep 2025
  • DEFA14ADefinitive additional materials9 Sep 2025
  • DEFM14ADefinitive proxy statement (merger)8 Sep 2025
  • PREM14APreliminary proxy statement (merger)26 Aug 2025
  • DEF 14CDefinitive information statement6 Aug 2025
  • PREM14APreliminary proxy statement (merger)24 Jul 2025
  • PRE 14CPreliminary information statement9 Jul 2025
  • PRE 14APreliminary proxy statement23 Sep 2024
  • PRER14APreliminary proxy statement (revision)18 Aug 2023
  • DEF 14ADefinitive proxy statement1 May 2023
  • DEFA14ADefinitive additional materials17 Feb 2023
  • DEF 14ADefinitive proxy statement15 Feb 2023
  • PRE 14APreliminary proxy statement27 Jan 2023

Registrations(68)

Expand
  • 424B3Prospectus filing (Rule 424(b)(3))14 Aug 2023
  • S-1/ARegistration statement (general form, amendment)3 Aug 2023
  • S-1Registration statement (general form)10 Jul 2023
  • 25-NSENotification of removal from listing27 Oct 2022
  • 424B3Prospectus filing (Rule 424(b)(3))30 Sep 2022
  • S-1Registration statement (general form)23 Sep 2022
  • 424B5Prospectus filing (Rule 424(b)(5))23 May 2022
  • 424B5Prospectus filing (Rule 424(b)(5))20 May 2022
  • S-8Registration statement (employee benefit plan)10 Mar 2022
  • 424B5Prospectus filing (Rule 424(b)(5))1 Mar 2022
  • 424B5Prospectus filing (Rule 424(b)(5))16 Feb 2022
  • 424B5Prospectus filing (Rule 424(b)(5))13 Jan 2022
  • 424B5Prospectus filing (Rule 424(b)(5))12 Oct 2021
  • S-3Registration statement (primary offering)30 Jul 2021
  • 424B5Prospectus filing (Rule 424(b)(5))19 May 2021

Filing Review Correspondence(13)

Expand
  • CORRESPFiling review correspondence10 Aug 2023
  • CORRESPFiling review correspondence3 Aug 2023
  • CORRESPFiling review correspondence28 Sep 2022
  • CORRESPFiling review correspondence3 Aug 2021
  • CORRESPFiling review correspondence9 Mar 2021
  • CORRESPFiling review correspondence26 Nov 2019
  • CORRESPFiling review correspondence28 Jun 2019
  • CORRESPFiling review correspondence3 May 2019
  • CORRESPFiling review correspondence17 May 2018
  • CORRESPFiling review correspondence17 May 2018
  • CORRESPFiling review correspondence2 Apr 2018
  • CORRESPFiling review correspondence27 Mar 2018
  • CORRESPFiling review correspondence9 Dec 2015

SEC Orders And Notices(15)

Expand
  • EFFECTNotice of effectiveness14 Aug 2023
  • EFFECTNotice of effectiveness30 Sep 2022
  • EFFECTNotice of effectiveness5 Aug 2021
  • EFFECTNotice of effectiveness11 Mar 2021
  • EFFECTNotice of effectiveness2 Dec 2019
  • EFFECTNotice of effectiveness2 Jul 2019
  • EFFECTNotice of effectiveness7 May 2019
  • EFFECTNotice of effectiveness21 May 2018
  • EFFECTNotice of effectiveness2 May 2018
  • EFFECTNotice of effectiveness3 Apr 2018
  • EFFECTNotice of effectiveness12 Dec 2017
  • CT ORDERConfidential treatment order28 Nov 2017
  • EFFECTNotice of effectiveness10 Dec 2015
  • CT ORDERConfidential treatment order21 Nov 2014
  • EFFECTNotice of effectiveness19 Nov 2014

Exempt Offerings(11)

Expand
  • D06b2 Jul 2025
  • D06b15 Apr 2025
  • D06b21 Aug 2024
  • D06b21 Aug 2024
  • D06b11 Oct 2023
  • D06b6 Mar 2023
  • D06b3 Feb 2023
  • D06b16 Oct 2020
  • D06b6 May 2020
  • D06b22 Apr 2019
  • D06b14 Feb 2019

Other(1)

Expand
  • CERTNASAUTO-GENERATED PAPER DOCUMENT19 Nov 2014

Financials(52)

Expand
  • 10-QQ3ended 30 Sept 202604:57PM
  • 10-QQ2ended 30 Jun 202614 Aug
  • 10-QQ1ended 31 Mar 202615 May
  • 10-KFY 2025ended 31 Dec 202511 Mar
  • 10-QQ3ended 30 Sept 202513 Nov 2025
  • 10-QQ2ended 30 Jun 202514 Aug 2025
  • 10-QQ1ended 31 Mar 202515 May 2025
  • 10-K/AFY 2024ended 31 Dec 202428 Mar 2025
  • 10-KFY 2024ended 31 Dec 202424 Mar 2025
  • 10-QQ3ended 30 Sept 202414 Nov 2024
  • 10-QQ2ended 30 Jun 202414 Aug 2024
  • 10-QQ1ended 31 Mar 202415 May 2024
  • 10-KFY 2023ended 31 Dec 202327 Mar 2024
  • 10-QQ3ended 30 Sept 202314 Nov 2023
  • 10-QQ2ended 30 Jun 202314 Aug 2023

Events(246)

Expand
  • 8-KResults of Operations and Financial Condition04:59PM
  • 8-KEntry into a Material Definitive Agreement15 Oct
  • 8-KEntry into a Material Definitive Agreement23 Sep
  • 8-KRegulation FD Disclosure20 Jul
  • 8-KEntry into a Material Definitive Agreement14 Jul
  • 8-KResults of Operations and Financial Condition18 May
  • 8-KEntry into a Material Definitive Agreement30 Apr
  • 8-KEntry into a Material Definitive Agreement16 Apr
  • 8-KTermination of a Material Definitive Agreement19 Mar
  • 8-KResults of Operations and Financial Condition11 Mar
  • 8-KRegulation FD Disclosure12 Jan
  • 8-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year26 Nov 2025
  • 8-KResults of Operations and Financial Condition13 Nov 2025
  • 8-KTermination of Material Agreement20 Oct 2025
  • 8-KEntry into Material Agreement17 Oct 2025

Insider Ownership(281)

Expand
  • Form 4Zhang Yan12 Jan 2024
  • Form 4Kamdar Kim P.22 Dec 2023
  • Form 5File Justin J.8 May 2023
  • Form 3Zhang Yan26 Apr 2023
  • Form 4PELLETIER SAUNDRA L26 Apr 2023
  • Form 3Yip Jenny C.8 Aug 2022
  • Form 3Atkinson Katherine Cocca7 Jun 2022
  • Form 4PELLETIER SAUNDRA L31 May 2022
  • Form 4O'Brien Anthony Stephen6 May 2022
  • Form 4Kamdar Kim P.6 May 2022
  • Form 4Rarick Lisa Dale6 May 2022
  • Form 4Rutherford Colin6 May 2022
  • Form 4Greer Gillian6 May 2022
  • Form 4Fitzpatrick Alexander A23 Feb 2022
  • Form 4PELLETIER SAUNDRA L23 Feb 2022

Beneficial Ownership(56)

Expand
  • SC 13DEvofem Biosciences, Inc.4 Aug
  • SC 13G/AEvofem Biosciences, Inc.14 Feb 2024
  • SC 13G/AEvofem Biosciences, Inc.14 Feb 2023
  • SC 13G/AEvofem Biosciences, Inc.10 Aug 2022
  • SC 13GEvofem Biosciences, Inc.19 Jul 2022
  • SC 13G/AEvofem Biosciences, Inc.14 Feb 2022
  • SC 13G/AEvofem Biosciences, Inc.10 Sep 2021
  • SC 13G/AEvofem Biosciences, Inc.12 Jul 2021
  • SC 13GEvofem Biosciences, Inc.4 Jun 2021
  • SC 13GEvofem Biosciences, Inc.28 May 2021
  • SC 13D/AEvofem Biosciences, Inc.20 May 2021
  • SC 13D/AEvofem Biosciences, Inc.27 Apr 2021
  • SC 13D/AEvofem Biosciences, Inc.31 Mar 2021
  • SC 13G/AEvofem Biosciences, Inc.12 Feb 2021
  • SC 13GEvofem Biosciences, Inc.2 Feb 2021

Proxies(43)

Expand
  • DEF 14ADefinitive proxy statement29 Oct 2025
  • PRE 14APreliminary proxy statement20 Oct 2025
  • DEFA14ADefinitive additional materials19 Sep 2025
  • DEFA14ADefinitive additional materials9 Sep 2025
  • DEFM14ADefinitive proxy statement (merger)8 Sep 2025
  • PREM14APreliminary proxy statement (merger)26 Aug 2025
  • DEF 14CDefinitive information statement6 Aug 2025
  • PREM14APreliminary proxy statement (merger)24 Jul 2025
  • PRE 14CPreliminary information statement9 Jul 2025
  • PRE 14APreliminary proxy statement23 Sep 2024
  • PRER14APreliminary proxy statement (revision)18 Aug 2023
  • DEF 14ADefinitive proxy statement1 May 2023
  • DEFA14ADefinitive additional materials17 Feb 2023
  • DEF 14ADefinitive proxy statement15 Feb 2023
  • PRE 14APreliminary proxy statement27 Jan 2023

Registrations(68)

Expand
  • 424B3Prospectus filing (Rule 424(b)(3))14 Aug 2023
  • S-1/ARegistration statement (general form, amendment)3 Aug 2023
  • S-1Registration statement (general form)10 Jul 2023
  • 25-NSENotification of removal from listing27 Oct 2022
  • 424B3Prospectus filing (Rule 424(b)(3))30 Sep 2022
  • S-1Registration statement (general form)23 Sep 2022
  • 424B5Prospectus filing (Rule 424(b)(5))23 May 2022
  • 424B5Prospectus filing (Rule 424(b)(5))20 May 2022
  • S-8Registration statement (employee benefit plan)10 Mar 2022
  • 424B5Prospectus filing (Rule 424(b)(5))1 Mar 2022
  • 424B5Prospectus filing (Rule 424(b)(5))16 Feb 2022
  • 424B5Prospectus filing (Rule 424(b)(5))13 Jan 2022
  • 424B5Prospectus filing (Rule 424(b)(5))12 Oct 2021
  • S-3Registration statement (primary offering)30 Jul 2021
  • 424B5Prospectus filing (Rule 424(b)(5))19 May 2021

Filing Review Correspondence(13)

Expand
  • CORRESPFiling review correspondence10 Aug 2023
  • CORRESPFiling review correspondence3 Aug 2023
  • CORRESPFiling review correspondence28 Sep 2022
  • CORRESPFiling review correspondence3 Aug 2021
  • CORRESPFiling review correspondence9 Mar 2021
  • CORRESPFiling review correspondence26 Nov 2019
  • CORRESPFiling review correspondence28 Jun 2019
  • CORRESPFiling review correspondence3 May 2019
  • CORRESPFiling review correspondence17 May 2018
  • CORRESPFiling review correspondence17 May 2018
  • CORRESPFiling review correspondence2 Apr 2018
  • CORRESPFiling review correspondence27 Mar 2018
  • CORRESPFiling review correspondence9 Dec 2015

SEC Orders And Notices(15)

Expand
  • EFFECTNotice of effectiveness14 Aug 2023
  • EFFECTNotice of effectiveness30 Sep 2022
  • EFFECTNotice of effectiveness5 Aug 2021
  • EFFECTNotice of effectiveness11 Mar 2021
  • EFFECTNotice of effectiveness2 Dec 2019
  • EFFECTNotice of effectiveness2 Jul 2019
  • EFFECTNotice of effectiveness7 May 2019
  • EFFECTNotice of effectiveness21 May 2018
  • EFFECTNotice of effectiveness2 May 2018
  • EFFECTNotice of effectiveness3 Apr 2018
  • EFFECTNotice of effectiveness12 Dec 2017
  • CT ORDERConfidential treatment order28 Nov 2017
  • EFFECTNotice of effectiveness10 Dec 2015
  • CT ORDERConfidential treatment order21 Nov 2014
  • EFFECTNotice of effectiveness19 Nov 2014

Exempt Offerings(11)

Expand
  • D06b2 Jul 2025
  • D06b15 Apr 2025
  • D06b21 Aug 2024
  • D06b21 Aug 2024
  • D06b11 Oct 2023
  • D06b6 Mar 2023
  • D06b3 Feb 2023
  • D06b16 Oct 2020
  • D06b6 May 2020
  • D06b22 Apr 2019
  • D06b14 Feb 2019

Other(1)

Expand
  • CERTNASAUTO-GENERATED PAPER DOCUMENT19 Nov 2014